Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma

Lancet. 1998 Sep 12;352(9131):908-9. doi: 10.1016/s0140-6736(05)60052-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interleukin-2 / administration & dosage*
  • Interleukin-2 / adverse effects
  • Melanoma / therapy*
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Interferon-alpha
  • Interleukin-2